Av-VITE FB Forte

Manufacturer
AvKARE, Inc.
Effective date
2016-04-11
Label type
DIETARY SUPPLEMENT
Version
3
Source
legacy-cache
Hydrated at
2026-08-02 01:27:37

Label at a glance#

ProductAv-VITE FB Forte
Active ingredientPYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN
Label structure10 sections

Label contents#

Full prescribing information#

STATEMENT OF IDENTITY SECTION

DESCRIPTION: Av-VITE FB Forte Tablets are an orally administered prescription dietary supplement for the management of patients requiring increased folate levels.

 Av-VITE FB Forte Tablets should be administered under the supervision of a licensed medical practitioner.

Supplement Facts
Serving Size: 1 Tablet
Amount Per Serving% Daily Value
        
Vitamin B6 (as Pyridoxine HCl)25 mg1250%
Folic Acid2.5 mg625%
Vitamin B12 (as Cyanocobalamin)2 mg33333%

Other Ingredients: Dibasic Calcium Phosphate Dihydrate, Microcrystalline Cellulose, Opadry II Beige 40L17427 (Titanium Dioxide, Polydextrose, Hypromellose 3cP, Hypromellose 6cP, Triacetin, Hypromellose 50cP, Polyethylene Glycol 8000, FD&C Yellow # 6 Aluminum Lake, FD&C Blue # 2 Aluminum Lake, FD&C Red #40 Aluminum Lake), Croscarmellose Sodium, Opadry II Clear #Y-19-7483 (Hypromellose 6cP, Maltodextrin, Hypromellose 3cP, Polyethylene Glycol 400, Hypromellose 50cP) Magnesium Stearate.

Contains: FD&C Yellow #6 Aluminum Lake, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake

WARNINGS SECTION

ALLERGY STATEMENT: This product has been manufactured in a facility that also manufactures products containing milk and soy. Individuals with allergic tendencies to these substances should use discretion.

Allergic reactions have been reported following the use of oral folate.

Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body have been associated with cobalamin.

Paresthesia, somnolence, nausea, and headaches have been reported with pyridoxine.

HEALTH CLAIM SECTION

CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the components contained in this product.

WARNINGS SECTION

CAUTION: High levels of folic acid may, especially in older adults, hide signs of vitamin B-12 deficiency (such as pernicious anemia), a condition that can cause nerve damage.

WARNINGS SECTION

INTERACTIONS: Drugs which may interact with folate include but are not limited to:

  • First generation anticonvulsants (folate may reduce their effectiveness)
  • Capecitabine (folate may enhance its toxicity)
  • Fluorouracil (folate may enhance its toxicity)

Drugs which may interact with folate metabolism include, but are not limited to:

•Dihydrofolate Reductase Inhibitors
•Fluoxetine
•Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
•Sulfasalazine
•Warfarin

Drugs which may interfere with the absorption of folate from the gastrointestinal tract or decrease plasma levels include, but are not limited to:

•Cholestyramine
•Colestipol
•Oral Contraceptives
•Methylprednisolone
•Pancreatic Enzymes
•Pentamidine
•Smoking and Alcohol
•Sulfasalazine
•Metformin

Drugs which may interact with vitamin B6 include, but are not limited to:

•Levodopa (the action of levodopa may be antagonized by vitamin B6)
 

Drugs which may interact with vitamin B12 include but are not limited to:

•Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic, and potassium chloride (may decrease the absorption of vitamin B12).
•Nitrous oxide (can produce a functional vitamin B12 deficiency).

HEALTH CLAIM SECTION

PREGNANCY and NURSING MOTHERS: Av-VITE FB Forte Tablets are not intended for use as a prenatal/postnatal multivitamin for lactating or nonlactating mothers. This product contains only B vitamins. Talk with your medical practitioner before using if pregnant or lactating.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION: One to two tablets daily or as directed by a licensed medical practitioner.

STORAGE: Store at room temperature 15° to 30°C (59° to 86°F). 

HEALTH CLAIM SECTION

HOW SUPPLIED: Av-VITE FB Forte Tablets are round, coated, beige colored tablets imprinted on one side with "V201", and are supplied in bottles of 90 tablets NDC 42291-151-90.

SAFE HANDLING WARNING SECTION

KEEP THIS OUT OF REACH OF CHILDREN.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Call your medical practitioner about side effects.

You may report side effects by calling AvKARE, Inc. at 1-855-361-3993 or FDA at 1-800-FDA-1088.

Manufactured for:                     
AvKARE, Inc.
Pulaski, TN 38478                 

Mfg. Rev. 06/15
AV 04/16 (P)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

AvKARE
NDC
42291-151-90

Av-VITE FB Forte

Prescription Folic Acid-Containing Dietary Supplement

90 Tablets
Must be used under the supervision of a physician.

Supplement Facts

Serving Size: 1 Tablet

Amount Per Serving% Daily Value
Vitamin B6
(as Pyridoxine HCl)
25 mg1250%
Folic Acid2.5 mg625%
Vitamin B12
(as Cyanocobalamin)
2 mg33333%

Other Ingredients: Dibasic Calcium Phosphate Dihydrate, Microcrystalline Cellulose, Opadry II Beige 40L17427 (Titanium Dioxide, Polydextrose, Hypromellose 3cP, Hypromellose 6cP, Triacetin, Hypromellose 50cP, Polyethylene Glycol 8000, FD&C Yellow #6 Aluminum Lake, FD&C Blue #2 Aluminum Lake, FD&C RED #40 Aluminum Lake), Croscarmellose Sodium, Opadry ll Clear #Y-19-7483 (Hypromellose 6cP, Maltodextrin, Hypromellose 3cP, Polyethylene Glycol 400, Hypromellose 50cP) Magnesium Stearate

Contains: FD&C Yellow #6 Aluminum Lake, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake.

DESCRIPTION:
Av-VITE FB Forte is an orally administered prescription dietary supplement and should be administered under the supervision of a licensed medical practitioner. See package insert for complete product information.

DIRECTION FOR USE: 1 or 2 tablet(s) daily or as directed by a physician.

WARNING: Keep this and all medications out of the reach of children.

CAUTION: High levels of folic acid may, especially in older adults, hide signs of Vitamin B-12 deficiency (such as
pernicious anemia), a condition that can cause nerve damage.

STORAGE: Store at room temperature, 15ºC to 30ºC (59ºF to 86ºF)

Call your licensed medical practitioner about side effects. You may report side effects by calling AvKARE at
855-361-3993 or FDA at 1-800-FDA-1088.

Manufactured for:
AvKARE, Inc.
Pulaski, TN 38478

Mfg. Rev. 06/15         AV 04/16 (P)

1 label
1 label
2 label
2 label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42291-151-90EA - Each42291-1510ea528c9-8a65-4f89-a451-c9a3468f39d312015-12-02
76439-365-90EA - Each76439-365a5ac6c71-ee4a-4359-8b2f-39ccc69a611c12015-08-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
CYANOCOBALAMINACTIVE INGREDIENTP6YC3EG2042
FOLIC ACIDACTIVE INGREDIENT935E97BOY82
PYRIDOXINE HYDROCHLORIDEACTIVE INGREDIENT68Y4CF58BV2
CYANOCOBALAMINACTIVE MOIETYP6YC3EG2042
FOLIC ACIDACTIVE MOIETY935E97BOY82
PYRIDOXINEACTIVE MOIETYKV2JZ1BI6Z2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O69332
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEINACTIVE INGREDIENTO7TSZ97GEP2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
Croscarmellose SodiumINACTIVE INGREDIENTM28OL1HH482
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQK2
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOA2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A82
Magnesium StearateINACTIVE INGREDIENT70097M6I302
MaltodextrinINACTIVE INGREDIENT7CVR7L4A2D2
PolydextroseINACTIVE INGREDIENTVH2XOU12IE2
Titanium DioxideINACTIVE INGREDIENT15FIX9V2JP2
TRIACETININACTIVE INGREDIENTXHX3C3X6732

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42291-15142291-151-90
76439-365

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 246 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, COATED / ORAL49 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SOLUTION / ORAL690 mgExact identifier — unii candidate
28 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEDIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPTABLET / ORAL2442 mgExact identifier — unii candidate
10 equally ranked IID candidates
PolydextrosePOLYDEXTROSEVH2XOU12IETABLET, EXTENDED RELEASE / ORAL22 mgExact identifier — unii candidate
3 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOASOLUTION / ORAL38 mgExact identifier — unii candidate
28 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEDIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPTABLET, EXTENDED RELEASE / ORAL1036 mgExact identifier — unii candidate
10 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / SUBLINGUAL43.2 mgExact identifier — unii candidate
28 equally ranked IID candidates
Croscarmellose SodiumCROSCARMELLOSE SODIUMM28OL1HH48TABLET, DELAYED RELEASE PARTICLES / ORAL64 mgExact identifier — unii candidate
22 equally ranked IID candidates
Croscarmellose SodiumCROSCARMELLOSE SODIUMM28OL1HH48SUSPENSION / ORAL150 mgExact identifier — unii candidate
22 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, FOR SUSPENSION / ORAL20100 mgExact identifier — unii candidate
28 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED, EXTENDED RELEASE / ORAL11 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOASUSPENSION / ORAL100 mg/5mlExact identifier — unii candidate
28 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, DELAYED RELEASE / ORAL66 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOAELIXIR / ORAL12.5 mg/5mlExact identifier — unii candidate
28 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKSOAP / TOPICALNAExact identifier — unii candidate
11 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8TABLET, FILM COATED / ORAL1 mgExact identifier — unii candidate
34 equally ranked IID candidates
Croscarmellose SodiumCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FOR SUSPENSION / ORAL1875 mgExact identifier — unii candidate
22 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
40 equally ranked IID candidates
MaltodextrinMALTODEXTRIN7CVR7L4A2DTABLET, EFFERVESCENT / ORAL14404 mgExact identifier — unii candidate
15 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
40 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8TABLET / ORAL60.02 mgExact identifier — unii candidate
34 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
34 equally ranked IID candidates
Croscarmellose SodiumCROSCARMELLOSE SODIUMM28OL1HH48TABLET, CHEWABLE / ORAL216 mgExact identifier — unii candidate
22 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET / BUCCAL0.01 mgExact identifier — unii candidate
11 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOATABLET, EXTENDED RELEASE / ORAL2.22 mgExact identifier — unii candidate
28 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOATABLET, FILM COATED / ORAL2.5 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, COATED PELLETS / ORAL456 mgExact identifier — unii candidate
28 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKTABLET, DELAYED RELEASE / ORAL0.2 mgExact identifier — unii candidate
11 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION, EXTENDED RELEASE / ORAL1120 mgExact identifier — unii candidate
28 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, COATED / ORAL184 mgExact identifier — unii candidate
39 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, COATED PELLETS / ORAL4.4 mgExact identifier — unii candidate
40 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30IMPLANT / INTRAVITREALNAExact identifier — unii candidate
39 equally ranked IID candidates
TRIACETINTRIACETINXHX3C3X673SYSTEM / TRANSDERMAL22.1 mgExact identifier — unii candidate
14 equally ranked IID candidates
MaltodextrinMALTODEXTRIN7CVR7L4A2DTABLET, CHEWABLE / ORAL292 mgExact identifier — unii candidate
15 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, DELAYED RELEASE / ORAL55 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8MOUTHWASH / BUCCAL0.01 mg/1mlExact identifier — unii candidate
34 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPSUPPOSITORY / VAGINALNAExact identifier — unii candidate
40 equally ranked IID candidates
MaltodextrinMALTODEXTRIN7CVR7L4A2DPASTE / ORAL1050 mgExact identifier — unii candidate
15 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE, EXTENDED RELEASE / ORAL1 mgExact identifier — unii candidate
28 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30TABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, FOR SUSPENSION / ORAL278 mgExact identifier — unii candidate
28 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACAPSULE / ORAL16 mgExact identifier — unii candidate
28 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPGUM, CHEWING / BUCCAL182 mgExact identifier — unii candidate
40 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii candidate
40 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING / ORAL6 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C YELLOW NO. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE, DELAYED RELEASE / ORAL0.02 mgExact identifier — unii candidate
34 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPPOWDER / ORAL2 mgExact identifier — unii candidate
40 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30GRANULE, FOR SUSPENSION / ORAL14 mgExact identifier — unii candidate
39 equally ranked IID candidates
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEDIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPCAPSULE / ORAL400 mgExact identifier — unii candidate
10 equally ranked IID candidates
Magnesium StearateMAGNESIUM STEARATE70097M6I30GRANULE / ORAL629 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UCAPSULE, EXTENDED RELEASE / ORAL1246 mgExact identifier — unii candidate
28 equally ranked IID candidates
ALUMINUM OXIDEALUMINUM OXIDELMI26O6933SPONGE / TOPICALNAExact identifier — unii candidate
2 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE, LIQUID FILLED / ORAL12 mgExact identifier — unii candidate
40 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED / ORAL36 mgExact identifier — unii candidate
40 equally ranked IID candidates
Titanium DioxideTITANIUM DIOXIDE15FIX9V2JPPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
40 equally ranked IID candidates
FD&C RED NO. 40FD&C RED NO. 40WZB9127XOACONCENTRATE / ORAL0.04 mg/1mlExact identifier — unii candidate
28 equally ranked IID candidates
FD&C BLUE NO. 2FD&C BLUE NO. 2L06K8R7DQKCAPSULE / ORAL4 mgExact identifier — unii candidate
11 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UGRANULE, DELAYED RELEASE / ORAL789.6 mgExact identifier — unii candidate
28 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Pyridoxine HydrochloridePYRIDOXINE HYDROCHLORIDEFresenius Kabi USA, LLCa56d11c0-b033-4201-85ff-fc710506481a2024-10-15Warnings, Adverse reactionsName fallback
generic name: PYRIDOXINE HYDROCHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.